Methodology for identification of pore forming antimicrobial peptides from soy protein subunits β-conglycinin and glycinin

Peptides. 2016 Nov:85:27-40. doi: 10.1016/j.peptides.2016.09.004. Epub 2016 Sep 6.

Abstract

Antimicrobial peptides (AMPs) inactivate microbial cells through pore formation in cell membrane. Because of their different mode of action compared to antibiotics, AMPs can be effectively used to combat drug resistant bacteria in human health. AMPs can also be used to replace antibiotics in animal feed and immobilized on food packaging films. In this research, we developed a methodology based on mechanistic evaluation of peptide-lipid bilayer interaction to identify AMPs from soy protein. Production of AMPs from soy protein is an attractive, cost-saving alternative for commercial consideration, because soy protein is an abundant and common protein resource. This methodology is also applicable for identification of AMPs from any protein. Initial screening of peptide segments from soy glycinin (11S) and soy β-conglycinin (7S) subunits was based on their hydrophobicity, hydrophobic moment and net charge. Delicate balance between hydrophilic and hydrophobic interactions is necessary for pore formation. High hydrophobicity decreases the peptide solubility in aqueous phase whereas high hydrophilicity limits binding of the peptide to the bilayer. Out of several candidates chosen from the initial screening, two peptides satisfied the criteria for antimicrobial activity, viz. (i) lipid-peptide binding in surface state and (ii) pore formation in transmembrane state of the aggregate. This method of identification of antimicrobial activity via molecular dynamics simulation was shown to be robust in that it is insensitive to the number of peptides employed in the simulation, initial peptide structure and force field. Their antimicrobial activity against Listeria monocytogenes and Escherichia coli was further confirmed by spot-on-lawn test.

Keywords: Antimicrobial peptides; Escherichia coli; Listeria monocytogenes; Molecular dynamics; Soy protein.

MeSH terms

  • Amino Acid Sequence / genetics
  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / pharmacology
  • Antigens, Plant / chemistry
  • Antigens, Plant / genetics*
  • Antigens, Plant / pharmacology
  • Antimicrobial Cationic Peptides / chemistry
  • Antimicrobial Cationic Peptides / genetics*
  • Antimicrobial Cationic Peptides / pharmacology
  • Cell Membrane / drug effects
  • Cell Membrane / genetics
  • Escherichia coli / drug effects
  • Escherichia coli / pathogenicity
  • Globulins / chemistry
  • Globulins / genetics*
  • Globulins / pharmacology
  • Glycine max / chemistry
  • Glycine max / genetics
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Infections / drug therapy*
  • Infections / genetics
  • Infections / microbiology
  • Lipid Bilayers / chemistry
  • Listeria monocytogenes / drug effects
  • Listeria monocytogenes / pathogenicity
  • Molecular Dynamics Simulation
  • Seed Storage Proteins / chemistry
  • Seed Storage Proteins / genetics*
  • Seed Storage Proteins / pharmacology
  • Soybean Proteins / chemistry
  • Soybean Proteins / genetics*
  • Soybean Proteins / pharmacology

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Antigens, Plant
  • Antimicrobial Cationic Peptides
  • Globulins
  • Lipid Bilayers
  • Seed Storage Proteins
  • Soybean Proteins
  • beta-conglycinin protein, Glycine max
  • glycinin